gelteq.com (GELS) Quarterly EPS earnings growth

Symbol and logo of brand gelteq.com (GELS)

Comparable quarterly EPS growth demonstrates the scaling dynamics of Gelteq Limited (GELS) and its innovative nutrient and medication delivery system. The current value is maintained at 0.00, confirming the business's resilience. Inertia technology extends the commercial cycle of drugs, protecting margins from generics. High physician confidence is based on the convenience of gel forms for children, which significantly improves patient adherence to treatment.

GELS: Gelteq Year-over-year earnings per one share growth for the last 12 months 10/30/2024 - 11/15/2026

gelteq.com (GELS) - metric breakdowns and financial figures

- share price and expert price forecast:
Stock Price gelteq.com|GELS - Average Forecast Price
- market capitalization details:
Market Capitalization Gelteq Ltd|GELS - Business Value
- balance sheet net asset value indicators:
Accounting Value per Share Gelteq|GELS - Accounting Value of Company|Market Value to Book Value Ratio gelteq.com|GELS - Total Asset Value of Company
- debt and solvency information:
Total Debt to Capital Gelteq Limited|GELS - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Gelteq|GELS - Company Aggregate Debts|Debt to Book Capitalization Ratio Gelteq Limited|GELS - Company Long-Term Loans and Borrowings|Company Short-Term Debt Gelteq|Quick Ratio gelteq.com
- earnings and valuation multiples information:
GELS - Net Profit|Projected Future Earnings Gelteq Limited|GELS - Market Cap to Net Income Ratio|Forward P/E Multiple gelteq.com|GELS - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Gelteq|GELS - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Gelteq|GELS - Earnings per share for the last four quarters|Quarterly EPS earnings growth gelteq.com|GELS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Gelteq Limited
- sales revenue and business income indicators:
GELS - Company Total Sales Volume|Company Future Sales Volume Gelteq Limited Inc|GELS - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio Gelteq|GELS - Sales Growth YoY (Last Twelve Months)
Initial company analysis:Gelteq Limited
Flagship merchandise of Gelteq Limited

Quarterly EPS growth measures the dynamics of net profit per share, allowing for the tracking of operational efficiency in real time through the quarterly EPS gap. This indicator is calculated as the percentage deviation of current earnings from the previous period, which is critically important for Gelteq Limited (GELS) when monitoring the rate of capital expenditure on clinical trials in the absence of revenue.

Who Gelteq Limited competes with

VRTX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Alnylam Inc. (ALNY)|INSM (Insmed) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months UTHR (United Therapeutics Corporation)|Year-over-year net earnings per share growth for the last 12 months BMRN (BioMarin)|BBIO (BridgeBio Pharma) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth BGM (BGM Group Ltd)|COGT (Cogent Bio) - Year-over-year net earnings per share trend for the last twelve months|Xeris Biopharma - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months KROS (Keros Therapeutics)|ARCT: Quarterly EPS earnings growth|Eton Pharmaceuticals Inc (ETON) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Kamada Corp|FULC: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Abeona Therapeutics, Inc. (ABEO)|Year-over-year net earnings per share growth for the last 12 months Mereo BioPharma Group plc MREO|Year-over-year earnings per share growth for the last twelve months Protalix BioTherapeutics PLX|Quarterly EPS earnings growth Pliant Therapeutics PLRX|appliedtherapeutics.com - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months RNTX (Rein Therapeutics, Inc.)|AYTU (aytubio.com) - Year-over-year net earnings per share growth for the last 12 months|Chemomab Therapeutics Ltd - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months SRXH|Year-over-year earnings per share growth for the last twelve months PLRZ|Quarterly EPS earnings growth AEZS|Year-over-year earnings per share growth for the last twelve months CYTH (Cyclo Therapeutics, Inc)|Inozyme Pharma - Year-over-year net earnings per share growth for the last 12 months|Reneo Pharmaceuticals, Inc. (RPHM) - Earnings per share growth in annualized terms for the last twelve months|COSCIENS Bio - Quarterly EPS earnings growth